Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease.

about

Timed Release of Cerebrolysin Using Drug-Loaded Titanate Nanospheres Reduces Brain Pathology and Improves Behavioral Functions in Parkinson's Disease.Laminin functionalized biomimetic apatite to regulate the adhesion and proliferation behaviors of neural stem cells

P2860

Q47712262-5E8827B8-4B1C-4660-8285-9A7662CB4523 Q57817196-881A0B96-9D06-4FDA-B99D-05177242676B

P2860

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease.

Item

http://www.wikidata.org/entity/Q41832273

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Neuropeptide Treatment with Ce ...... Model of Parkinson's Disease.

@en

type

Item

label

Neuropeptide Treatment with Ce ...... Model of Parkinson's Disease.

@en

prefLabel

Neuropeptide Treatment with Ce ...... Model of Parkinson's Disease.

@en

P1476

Neuropeptide Treatment with Ce ...... Model of Parkinson's Disease.

@en

P2093

Anthony Adame

http://www.w3.org/2001/XMLSchema#string

Dieter Meier

http://www.w3.org/2001/XMLSchema#string

Hemma Brandstaetter

http://www.w3.org/2001/XMLSchema#string

Herbert Moessler

http://www.w3.org/2001/XMLSchema#string

Jazmin Florio

http://www.w3.org/2001/XMLSchema#string

Michael Mante

http://www.w3.org/2001/XMLSchema#string

Paula Desplats

http://www.w3.org/2001/XMLSchema#string

Stefan Winter

http://www.w3.org/2001/XMLSchema#string

P2860

α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells.

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein

Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Neurotrophic effects of Cerebrolysin in animal models of excitotoxicity.

Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders

Strengths and limitations of genetic mouse models of Parkinson's disease.

Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models

P304

131-140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/JEN.S25521

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eliezer Masliah

Edward Rockenstein

Kiren Ubhi

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27429559

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

Synuclein

P932

4938121

http://www.w3.org/2001/XMLSchema#string

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease.

about

P2860

P2860

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932